IP Verse

Treatment Comprising Oral Or Gastric Administration Of Edaravone

Patent No. EP3551181 (titled "Treatment Comprising Oral Or Gastric Administration Of Edaravone") was filed by Treeway TW on Jan 17, 2018. The application was issued on Nov 18, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BARDEHLE PAGENBERG PARTNERSCHAFT MBB PATENTANWALTEAug 18, 2021BARDEHLE PAGENBERG PARTNERSCHAFT MBB PATENTANWALTE RECHTSANWALTE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3551181

TREEWAY TW
Application Number
EP18701303A
Filing Date
Jan 17, 2018
Status
Opposition Rejected
Nov 10, 2023
Publication Date
Nov 18, 2020
External Links
Slate, Register , Google Patents